Marshall Wace, LLP Simulations Plus, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 102,077 shares of SLP stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102,077
Previous 47,219
116.18%
Holding current value
$3.24 Million
Previous $1.51 Million
88.35%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SLP
# of Institutions
172Shares Held
15.7MCall Options Held
11.1KPut Options Held
7.3K-
Black Rock Inc. New York, NY2.46MShares$78.3 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC2.23MShares$70.7 Million0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$36.4 Million0.0% of portfolio
-
State Street Corp Boston, MA721KShares$22.9 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX702KShares$22.3 Million1.27% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $645M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...